Home » Products » Pharmaceutical Drugs » VANTOX-CP 1 GM

VANTOX-CP 1 GM

VANTOX-CP 1 GM
VANTOX-CP 1 GM
Send Inquiry
Product Code : 015
Price And Quantity
  • Minimum Order Quantity
  • 100000
  • Unit of Measure
  • Piece/Pieces,
  • Price
  • 500 INR
Product Specifications
  • Drug Type
  • Injection
  • Physical Form
  • Liquid
  • Function
  • Anti-Bacterial
  • Recommended For
  • Bacterial Infections
  • Suitable For
  • Adults
Product Description

VANTOX-CP 1 GM
Typical Usages of VANTOX-CP 1 GM:

Bacteremia, brain abscesses, endocarditis, endocarditis prophylaxis, chronic myeloid leukaemia, acute leukemia, colitis, constipation and bowel evacuation, meningitis, peritonitis, endocarditis treatment, relentless neutropenia in advanced HIV contagion.
Indicators

Pregnancy:C Lactation:L5 Lab:NA Food:NA
Side Effects

Nephrotoxicity, renal damage, uremia, hematuria, proteinuria, fever, redness, hypotension, flushing, urticarial skin rash, eosinophilia, red man syndrome.

Drug Interaction

Vancomycin is known to interact with other drugs like amphotericin B, cyclosporin A, gentamicin, metformin (HCl), netilmicin (Sulphate), oxaliplatin, streptomycin, tobramycin. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Mechanism Of Action

Vancomycin prevents incorporation of N-acetylmuramic acid (NAM)- and N-acetylglucosamine (NAG)-peptide subunits from being incorporated into the peptidoglycan matrix; which forms the major structural component of Gram-positive cell walls. The large hydrophilic molecule is able to form hydrogen bond interactions with the terminal D-alanyl-D-alanine moieties of the NAM/NAG-peptides. This binding of vancomycin to the D-Ala-D-Ala prevents the incorporation of the NAM/NAG-peptide subunits into the peptidoglycan matrix and alters bacterial-cell-membrane permeability and RNA synthesis.

Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 100000 Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED
X


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.